| scholarly article | Q13442814 |
| P50 | author | Andrew Wang | Q37384501 |
| P2093 | author name string | Michael E Werner | |
| Tian Zhang | |||
| Ronald C Chen | |||
| Natalie D Cummings | |||
| Rohit Sukumar | |||
| Shrirang Karve | |||
| Jonathan A Copp | |||
| P2860 | cites work | Cancer statistics, 2010 | Q27860525 |
| Intraperitoneal therapy for peritoneal cancer | Q34789701 | ||
| Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform. | Q35771214 | ||
| Recent progress in the diagnosis and treatment of ovarian cancer | Q36622857 | ||
| The concurrent chemoradiation paradigm--general principles | Q36720868 | ||
| Beyond chemotherapy: targeted therapies in ovarian cancer | Q37399899 | ||
| Radioimmunotherapy for stem cell transplantation in non-Hodgkin's lymphoma: in pursuit of a complete response | Q37612633 | ||
| ChemoRad nanoparticles: a novel multifunctional nanoparticle platform for targeted delivery of concurrent chemoradiation. | Q39714462 | ||
| Chromic phosphate therapy in carcinoma of the ovary. | Q40628917 | ||
| Intraperitoneal chromic phosphate P 32 as salvage therapy for persistent carcinoma of the ovary after surgical restaging | Q43684037 | ||
| Intraperitoneal cisplatin and paclitaxel in ovarian cancer. | Q53263238 | ||
| Cancer of the ovary | Q72356478 | ||
| Biofunctionalized targeted nanoparticles for therapeutic applications | Q81610160 | ||
| P433 | issue | 33 | |
| P921 | main subject | nanoparticle | Q61231 |
| ovarian cancer | Q172341 | ||
| P1104 | number of pages | 7 | |
| P304 | page(s) | 8548-8554 | |
| P577 | publication date | 2011-08-16 | |
| P1433 | published in | Biomaterials | Q15751139 |
| P1476 | title | Folate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis. | |
| P478 | volume | 32 |
| Q55334502 | 111In-labelled polymeric nanoparticles incorporating a ruthenium-based radiosensitizer for EGFR-targeted combination therapy in oesophageal cancer cells. |
| Q36119585 | Antitumor activity of folate-targeted, paclitaxel-loaded polymeric micelles on a human esophageal EC9706 cancer cell line |
| Q37516225 | Application of nanotechnology to cancer radiotherapy |
| Q38491805 | Aptamer-Functionalized Nanoparticles as "Smart Bombs": The Unrealized Potential for Personalized Medicine and Targeted Cancer Treatment |
| Q39005226 | Cancer nanomedicine: progress, challenges and opportunities |
| Q34447986 | Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. |
| Q55686642 | Colloidal Polymeric Platform for Facile Click-Assisted Ligand Functionalization and Receptor Targeting. |
| Q52657240 | Comparison between multi-slice spiral CT and magnetic resonance imaging in the diagnosis of peritoneal metastasis in primary ovarian carcinoma. |
| Q91871531 | Current trends and challenges in cancer management and therapy using designer nanomaterials |
| Q39249056 | Cytoreductive surgery and intraoperative administration of paclitaxel-loaded expansile nanoparticles delay tumor recurrence in ovarian carcinoma |
| Q30421668 | Dawn of advanced molecular medicine: nanotechnological advancements in cancer imaging and therapy |
| Q36185327 | Delivery of RNA nanoparticles into colorectal cancer metastases following systemic administration |
| Q38067265 | Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery. |
| Q37683953 | Development of lipid-shell and polymer core nanoparticles with water-soluble salidroside for anti-cancer therapy |
| Q30421664 | Development of nanoscale approaches for ovarian cancer therapeutics and diagnostics |
| Q36744073 | Direct Observation of Early-Stage High-Dose Radiotherapy-Induced Vascular Injury via Basement Membrane-Targeting Nanoparticles |
| Q36402123 | Drug delivery systems for ovarian cancer treatment: a systematic review and meta-analysis of animal studies. |
| Q39393466 | Emerging Nanotechnology and Advanced Materials for Cancer Radiation Therapy. |
| Q64978113 | Enhanced Melanoma-Targeted Therapy by "Fru-Blocked" Phenyboronic Acid-Modified Multiphase Antimetastatic Micellar Nanoparticles. |
| Q51421010 | Folate-based single cell screening using surface enhanced Raman microimaging. |
| Q39289120 | Folate-modified gold nanoclusters as near-infrared fluorescent probes for tumor imaging and therapy |
| Q35694281 | Gelatinase-stimuli strategy enhances the tumor delivery and therapeutic efficacy of docetaxel-loaded poly(ethylene glycol)-poly(ɛ-caprolactone) nanoparticles |
| Q38286594 | Heterogeneous response of different tumor cell lines to methotrexate-coupled nanoparticles in presence of hyperthermia |
| Q38011794 | Image-guided nanosystems for targeted delivery in cancer therapy |
| Q39114835 | Improved Targeting of Cancers with Nanotherapeutics |
| Q34564219 | Improving chemoradiotherapy with nanoparticle therapeutics |
| Q38253121 | In pursuit of a moving target: nanotherapeutics for the treatment of non-Hodgkin B-cell lymphoma |
| Q34127625 | Insight into nanoparticle cellular uptake and intracellular targeting |
| Q37640704 | Intraperitoneal delivery of paclitaxel by poly(ether-anhydride) microspheres effectively suppresses tumor growth in a murine metastatic ovarian cancer model |
| Q38556750 | Lipid-coated polymeric nanoparticles for cancer drug delivery |
| Q64076280 | Lipid-polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives |
| Q38806793 | Liposomal drug delivery systems for targeted cancer therapy: is active targeting the best choice? |
| Q38150118 | Merging the best of both worlds: hybrid lipid-enveloped matrix nanocomposites in drug delivery |
| Q36838995 | Nanomedicine in chemoradiation. |
| Q28079572 | Nanomedicine in the application of uveal melanoma |
| Q47165034 | Nanoparticle as a novel tool in hyperthermic intraperitoneal and pressurized intraperitoneal aerosol chemotheprapy to treat patients with peritoneal carcinomatosis. |
| Q38785806 | Nanoparticles and radiotracers: advances toward radionanomedicine |
| Q53698499 | Nanotechnology for Cancer Therapy Based on Chemotherapy. |
| Q26801067 | Nanotechnology: Future of Oncotherapy |
| Q36840545 | Near-infrared fluorescent imaging of metastatic ovarian cancer using folate receptor-targeted high-density lipoprotein nanocarriers. |
| Q52765342 | Neutron-activatable radionuclide cancer therapy using graphene oxide nanoplatelets. |
| Q36425890 | Non-viral therapeutic approaches to ocular diseases: An overview and future directions |
| Q91741464 | Optimisation of Folate-Mediated Liposomal Encapsulated Arsenic Trioxide for Treating HPV-Positive Cervical Cancer Cells In Vitro |
| Q38888264 | Ovarian cancer immunotherapy using PD-L1 siRNA targeted delivery from folic acid-functionalized polyethylenimine: strategies to enhance T cell killing. |
| Q64900708 | Phase-shift, targeted nanoparticles for ultrasound molecular imaging by low intensity focused ultrasound irradiation. |
| Q39338877 | Phosphatidylinositol 3-kinase inhibitor (PIK75) containing surface functionalized nanoemulsion for enhanced drug delivery, cytotoxicity and pro-apoptotic activity in ovarian cancer cells |
| Q50193627 | Post-Synthetic Modification Nanoscale Metal-Organic Frameworks for Targeted Drug Delivery in Cancer Cells |
| Q38258602 | Potential nanotechnologies and molecular targets in the quest for efficient chemotherapy in ovarian cancer |
| Q36521096 | Prevention of nodal metastases in breast cancer following the lymphatic migration of paclitaxel-loaded expansile nanoparticles. |
| Q38755295 | Radiolabelled Polymeric Materials for Imaging and Treatment of Cancer: Quo Vadis? |
| Q37422977 | Rational Design of Materials Interface for Efficient Capture of Circulating Tumor Cells. |
| Q37626377 | Rigid nanoparticle-based delivery of anti-cancer siRNA: challenges and opportunities |
| Q34427093 | Self-assembled Targeting of Cancer Cells by Iron(III)-doped, Silica Nanoparticles |
| Q47589446 | Synthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic Applications |
| Q28066010 | Synthetic nanoparticles for delivery of radioisotopes and radiosensitizers in cancer therapy |
| Q38928745 | Targeting FR-expressing cells in ovarian cancer with Fab-functionalized nanoparticles: a full study to provide the proof of principle from in vitro to in vivo. |
| Q36589179 | Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances |
| Q37606583 | Telodendrimer-based nanocarriers for the treatment of ovarian cancer |
| Q38314361 | Tracking the down-regulation of folate receptor-α in cancer cells through target specific delivery of quantum dots coupled with antisense oligonucleotide and targeted peptide |
| Q34110128 | Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin |
| Q36980441 | Utilizing G2/M retention effect to enhance tumor accumulation of active targeting nanoparticles |
Search more.